Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.75
-0.42-19.35%
At close: Feb 13, 4:00 PM EST
$1.74
-0.01-0.57%
After Hours: 7:01 PM EST
Comments
Loading...
OKYO Pharma Ltd Analyst Ratings
OKYONASDAQ
OKYO Pharma Analyst Ratings and Price Targets | NASDAQ:OKYO | Benzinga
OKYO Pharma Ltd has a consensus price target of $6 based on the ratings of 2 analysts. The high is $7 issued by HC Wainwright & Co. on September 23, 2025. The low is $5 issued by B. Riley Securities on December 8, 2025. The 3 most-recent analyst ratings were released by B. Riley Securities, HC Wainwright & Co., and HC Wainwright & Co. on December 8, 2025, September 23, 2025, and May 5, 2025, respectively. With an average price target of $6.33 between B. Riley Securities, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 263.98% upside for OKYO Pharma Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B. Riley Securities
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for OKYO Pharma
FAQ
What is the target price for OKYO Pharma (OKYO) stock?
The latest price target for OKYO Pharma (NASDAQ:OKYO) was reported by B. Riley Securities on December 8, 2025. The analyst firm set a price target for $5.00 expecting OKYO to rise to within 12 months (a possible 187.36% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for OKYO Pharma (OKYO)?
The latest analyst rating for OKYO Pharma (NASDAQ:OKYO) was provided by B. Riley Securities, and OKYO Pharma initiated their buy rating.
When was the last upgrade for OKYO Pharma (OKYO)?
There is no last upgrade for OKYO Pharma
When was the last downgrade for OKYO Pharma (OKYO)?
There is no last downgrade for OKYO Pharma.
When is the next analyst rating going to be posted or updated for OKYO Pharma (OKYO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OKYO Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OKYO Pharma was filed on December 8, 2025 so you should expect the next rating to be made available sometime around December 8, 2026.
Is the Analyst Rating OKYO Pharma (OKYO) correct?
While ratings are subjective and will change, the latest OKYO Pharma (OKYO) rating was a initiated with a price target of $0.00 to $5.00. The current price OKYO Pharma (OKYO) is trading at is $1.74, which is within the analyst’s predicted range.
